Rapid Clinical Updates: Great Debates in Diabetes: Updates for the Hospitalist-Handout

Pdf Summary

The document summarizes key updates in type 2 diabetes treatment for hospitalists. The main theme is that diabetes care is no longer focused only on lowering A1C, but also on preventing cardiovascular, renal, and other complications with patient-centered, individualized therapy.<br /><br />It highlights newer medication classes developed over the past 5–10 years, especially GLP-1 receptor agonists and SGLT2 inhibitors. These agents do more than lower glucose: they can reduce cardiovascular risk, protect kidney function, and support weight loss. This reflects a stronger connection between cardiology, endocrinology, and nephrology in diabetes management.<br /><br />For inpatient care, the usual approach when patients are admitted is to hold home diabetes medications and use insulin-based regimens, such as sliding scale or low-dose physiologic insulin. However, if a patient is stable and eating, some home medications may be continued, though insulin and sulfonylurea doses may need reduction because of hypoglycemia risk. Hospitalization should also be used to reassess the outpatient regimen using the “3 C’s”: compliance, control, and comorbidities. Brief diabetes education focused on survival skills may also be needed.<br /><br />For discharge planning, the document stresses acting early and thinking about the home regimen soon after admission. Clinicians should consider what the patient can realistically manage after discharge, especially if insulin is involved. The discharge plan should again consider the 3 C’s and ensure appropriate prescriptions, supplies, and follow-up. Starting new diabetes agents at discharge may be difficult logistically, but patients should still receive guidance on the best long-term regimen for their situation.

Meta Tag

Concept Type 2 Diabetes

Concept GLP-1 Receptor Agonist

Concept SGLT-2 Inhibitors

Concept Glycemic Control

Concept Patient-Centered Care

Keywords

type 2 diabetes

hospitalist

GLP-1 receptor agonists

SGLT2 inhibitors

cardiovascular risk

kidney protection

insulin therapy

hypoglycemia risk

discharge planning

patient-centered care

Type 2 Diabetes

GLP-1 Receptor Agonist

SGLT-2 Inhibitors

Glycemic Control

Patient-Centered Care